Overview

Preoperative Levosimendan and Heart Failure

Status:
Withdrawn

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the safety and efficacy of Levosimendan given preoperative to patients with heart failure undergoing noncardiac surgery.

Phase:

Phase 4

Details

Lead Sponsor:

Sykehuset i Vestfold HF

Collaborator:

Orion Corporation, Orion Pharma

Treatments:

Simendan